Literature DB >> 14682360

Proteinase-activated receptors in the nervous system.

Farshid Noorbakhsh1, Nathalie Vergnolle, Morley D Hollenberg, Christopher Power.   

Abstract

Recent data point to important roles for proteinases and their cognate proteinase-activated receptors (PARs) in the ontogeny and pathophysiology of the nervous system. PARs are a family of G-protein-coupled receptors that can affect neural cell proliferation, morphology and physiology. PARs also have important roles in neuroinflammatory and degenerative diseases such as human immunodeficiency virus-associated dementia, Alzheimer's disease and pain. These receptors might also influence the pathogenesis of stroke and multiple sclerosis, conditions in which the blood-brain barrier is disrupted. The diversity of effects of PARs on neural function and their widespread distribution in the nervous system make them attractive therapeutic targets for neurological disorders. Here, we review the roles of PARs in the central and peripheral nervous systems during health and disease, with a focus on neuroinflammatory and degenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14682360     DOI: 10.1038/nrn1255

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  32 in total

Review 1.  Targeting proteinase-activated receptors: therapeutic potential and challenges.

Authors:  Rithwik Ramachandran; Farshid Noorbakhsh; Kathryn Defea; Morley D Hollenberg
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

2.  Proteinase-activated receptor-1 and -2 induce the release of chemokine GRO/CINC-1 from rat astrocytes via differential activation of JNK isoforms, evoking multiple protective pathways in brain.

Authors:  Yingfei Wang; Weibo Luo; Georg Reiser
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

3.  Pain TRP-ed up by PARs.

Authors:  Annmarie Surprenant
Journal:  J Physiol       Date:  2006-12-21       Impact factor: 5.182

Review 4.  Proteinase-activated receptors in the lower urinary tract.

Authors:  James D Moffatt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-02-10       Impact factor: 3.000

Review 5.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

Review 6.  Proteinases, their receptors and inflammatory signalling: the Oxford South Parks Road connection.

Authors:  M D Hollenberg
Journal:  Br J Pharmacol       Date:  2015-03-17       Impact factor: 8.739

7.  HIV-1 Tat promotes astrocytic release of CCL2 through MMP/PAR-1 signaling.

Authors:  P Lorenzo Bozzelli; Tao Yin; Valeria Avdoshina; Italo Mocchetti; Katherine E Conant; Kathleen A Maguire-Zeiss
Journal:  Glia       Date:  2019-05-23       Impact factor: 7.452

8.  Time course of upregulation of inflammatory mediators in the hemorrhagic brain in rats: correlation with brain edema.

Authors:  He Wu; Zhiyi Zhang; Ying Li; Ruibo Zhao; Heng Li; Yuejia Song; Jiping Qi; Jian Wang
Journal:  Neurochem Int       Date:  2010-06-10       Impact factor: 3.921

9.  Latrophilin fragments behave as independent proteins that associate and signal on binding of LTX(N4C).

Authors:  Kirill E Volynski; John-Paul Silva; Vera G Lelianova; M Atiqur Rahman; Colin Hopkins; Yuri A Ushkaryov
Journal:  EMBO J       Date:  2004-10-14       Impact factor: 11.598

10.  Neuroinflammation-Induced Interactions between Protease-Activated Receptor 1 and Proprotein Convertases in HIV-Associated Neurocognitive Disorder.

Authors:  WooJin Kim; Erin Zekas; Robert Lodge; Delia Susan-Resiga; Edwidge Marcinkiewicz; Rachid Essalmani; Koichiro Mihara; Rithwik Ramachandran; Eugene Asahchop; Benjamin Gelman; Éric A Cohen; Christopher Power; Morley D Hollenberg; Nabil G Seidah
Journal:  Mol Cell Biol       Date:  2015-08-17       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.